Wen W, Li H, Wang C, Chen C, Tang J, Zhou M, Hong X, Cheng Y, Wu Q, Zhang X, Feng Z, Wang M. Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: a meta-analysis. Front Endocrinol (Lausanne). 2022;13:934225. https://doi.org/10.3389/fendo.2022.934225.

Article  PubMed  Google Scholar 

Ore A, Akinloye OA. Phytotherapy as multi-hit therapy to confront the multiple pathophysiology in non-alcoholic fatty liver disease: a systematic review of experimental interventions. Medicina (Kaunas). 2021. https://doi.org/10.3390/medicina57080822.

Article  PubMed  Google Scholar 

Eslam M, El-Serag HB, Francque S, Sarin SK, Wei L, Bugianesi E, George J. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nat Rev Gastroenterol Hepatol. 2022;19(10):638–51. https://doi.org/10.1038/s41575-022-00635-5.

Article  PubMed  Google Scholar 

Lin H, Zhang X, Li G, Wong GL, Wong VW. Epidemiology and clinical outcomes of metabolic (dysfunction)-associated fatty liver disease. J Clin Transl Hepatol. 2021;9(6):972–82. https://doi.org/10.14218/jcth.2021.00201.

Article  PubMed  PubMed Central  Google Scholar 

Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis. 2016;20(2):205–14. https://doi.org/10.1016/j.cld.2015.10.001.

Article  PubMed  Google Scholar 

Golabi P, Paik J, Reddy R, Bugianesi E, Trimble G, Younossi ZM. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol. 2019;19(1):56. https://doi.org/10.1186/s12876-019-0972-6.

Article  PubMed  PubMed Central  Google Scholar 

Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol. 2021;75(6):1284–91. https://doi.org/10.1016/j.jhep.2021.07.035.

Article  CAS  PubMed  Google Scholar 

Kim KS, Hong S, Ahn HY, Park CY. Metabolic dysfunction-associated fatty liver disease and mortality: a population-based cohort study. Diabetes Metab J. 2023;47(2):220–31. https://doi.org/10.4093/dmj.2021.0327.

Article  PubMed  PubMed Central  Google Scholar 

Tana C, Ballestri S, Ricci F, Di Vincenzo A, Ticinesi A, Gallina S, Giamberardino MA, Cipollone F, Sutton R, Vettor R, Fedorowski A, Meschi T. Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications. Int J Environ Res Public Health. 2019. https://doi.org/10.3390/ijerph16173104.

Article  PubMed  PubMed Central  Google Scholar 

Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33. https://doi.org/10.1002/hep.29466.

Article  CAS  PubMed  Google Scholar 

Mantovani A, Dalbeni A. Treatments for NAFLD: state of art. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22052350.

Article  PubMed  PubMed Central  Google Scholar 

Ludwig DS, Hu FB, Tappy L, Brand-Miller J. Dietary carbohydrates: role of quality and quantity in chronic disease. BMJ. 2018;361:k2340. https://doi.org/10.1136/bmj.k2340.

Article  PubMed  PubMed Central  Google Scholar 

Sievenpiper JL. Low-carbohydrate diets and cardiometabolic health: the importance of carbohydrate quality over quantity. Nutr Rev. 2020;78(Suppl 1):69–77. https://doi.org/10.1093/nutrit/nuz082.

Article  PubMed  PubMed Central  Google Scholar 

Campos V, Tappy L, Bally L, Sievenpiper JL, Lê KA. Importance of carbohydrate quality: What does it mean and how to measure it? J Nutr. 2022;152(5):1200–6. https://doi.org/10.1093/jn/nxac039.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613. https://doi.org/10.1161/circulationaha.109.192703.

Article  PubMed  Google Scholar 

Hashimoto Y, Tanaka M, Miki A, Kobayashi Y, Wada S, Kuwahata M, Kido Y, Yamazaki M, Fukui M. Intake of carbohydrate to fiber ratio is a useful marker for metabolic syndrome in patients with type 2 diabetes: a cross-sectional study. Ann Nutr Metab. 2018;72(4):329–35. https://doi.org/10.1159/000486550.

Article  CAS  PubMed  Google Scholar 

Fontanelli MM, Micha R, Sales CH, Liu J, Mozaffarian D, Fisberg RM. Application of the ≤ 10:1 carbohydrate to fiber ratio to identify healthy grain foods and its association with cardiometabolic risk factors. Eur J Nutr. 2020;59(7):3269–79. https://doi.org/10.1007/s00394-019-02165-4.

Article  CAS  PubMed  Google Scholar 

Dong Q, Wang L, Hu H, Cui L, Lu A, Qian C, Wang X, Du X. Greater protection of lower dietary carbohydrate to fiber ratio (CFR) against poor blood pressure control in patients with essential hypertension: a cross-sectional study. Nutrients. 2022. https://doi.org/10.3390/nu14214443.

Article  PubMed  PubMed Central  Google Scholar 

Zhao H, Yang A, Mao L, Quan Y, Cui J, Sun Y. Association between dietary fiber intake and non-alcoholic fatty liver disease in adults. Front Nutr. 2020;7:593735. https://doi.org/10.3389/fnut.2020.593735.

Article  CAS  PubMed  PubMed Central  Google Scholar 

N. C. F. H. Statistics: about NHANES. 2022 [cited 2023 October]; Available from: https://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Lédinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Jung KS, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022–30. https://doi.org/10.1016/j.jhep.2016.12.022.

Article  PubMed  Google Scholar 

Weng Z, Ou W, Huang J, Singh M, Wang M, Zhu Y, Kumar R, Lin S. Circadian misalignment rather than sleep duration is associated with MAFLD: a population-based propensity score-matched study. Nat Sci Sleep. 2021;13:103–11. https://doi.org/10.2147/nss.S290465.

Article  PubMed  PubMed Central  Google Scholar 

Morimoto N, Urayama KY, Tanaka A, Ai M. Relationship between dietary fiber to carbohydrate ratio and mortality risk in US adults: NHANES 2007–2018. Nutr Metab Cardiovasc Dis. 2024;34(3):661–71. https://doi.org/10.1016/j.numecd.2023.11.002.

Article  CAS  PubMed  Google Scholar 

Sun B, Shi X, Wang T, Zhang D. Exploration of the association between dietary fiber intake and hypertension among U.S. adults using 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: NHANES 2007–2014. Nutrients. 2018. https://doi.org/10.3390/nu10081091.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Lin Z, Chen J, Gan D, Zhou H, Ma Z, Zeng X, Xue Y, Wang X, Zhan Q, Zeng Q, Xu D. Association between dietary fiber intake and heart failure among adults: National Health and Nutrition Examination Survey 2009–2018. Front Cardiovasc Med. 2022;9:893436. https://doi.org/10.3389/fcvm.2022.893436.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zhang J, Zhou J, Ernstsen L, Lavie CJ, Hooker SP, Sui X. Nonexercise estimated cardiorespiratory fitness and mortality due to all causes and cardiovascular disease: the NHANES III study. Mayo Clin Proc Innov Qual Outcomes. 2017;1(1):16–25. https://doi.org/10.1016/j.mayocpiqo.2017.04.007.

Article  PubMed  PubMed Central  Google Scholar 

Liu Z, Lin C, Suo C, Zhao R, Jin L, Zhang T, Chen X. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism. 2022;127:154955. https://doi.org/10.1016/j.metabol.2021.154955.

Article  CAS  PubMed  Google Scholar 

Sawicki CM, Lichtenstein AH, Rogers GT, Jacques PF, Ma J, Saltzman E, McKeown NM. Comparison of indices of carbohydrate quality and food sources of dietary fiber on longitudinal changes in waist circumference in the Framingham offspring cohort. Nutrients. 2021. https://doi.org/10.3390/nu13030997.

Article  PubMed  PubMed Central  Google Scholar 

AlEssa HB, Bhupathiraju SN, Malik VS, Wedick NM, Campos H, Rosner B, Willett WC, Hu FB. Carbohydrate quality and quantity and risk of type 2 diabetes in US women. Am J Clin Nutr. 2015;102(6):1543–53. https://doi.org/10.3945/ajcn.115.116558.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Y, Yang H, Zhang Y, Rao S, Mo Y, Zhang H, Liang S, Zhang Z, Yang W. Dietary fiber intake and non-alcoholic fatty liver disease: the mediating role of obesity. Front Public Health. 2022;10:1038435. https://doi.org/10.3389/fpubh.2022.1038435.

Article  PubMed  Google Scholar 

Rietman A, Sluik D, Feskens EJM, Kok FJ, Mensink M. Associations between dietary factors and markers of NAFLD in a general Dutch adult population. Eur J Clin Nutr. 2018;72(1):117–23. https://doi.org/10.1038/ejcn.2017.148.

Article  CAS  PubMed  Google Scholar 

Xia Y, Zhang S, Zhang Q, Liu L, Meng G, Wu H, Bao X, Gu Y, Sun S, Wang X, Zhou M, Jia Q, Song K, Wu Q, Niu K, Zhao Y. Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional study. Nutr Metab (Lond). 2020. https://doi.org/10.1186/s12986-019-0420-1.

Article